(XCS7) Xtrackers MSCI China 1D - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2456436083

Chinese, Stocks, Equity, Investments, China

Description: XCS7 Xtrackers MSCI China 1D

The Xtrackers MSCI China UCITS ETF 1D EUR (XETRA:XCS7) is an exchange-traded fund that tracks the Morningstar China TME NR USD index, providing investors with exposure to the Chinese equity market. As a Germany-originated ETF, it is listed on the XETRA exchange and falls under the China Equity category.

From a technical standpoint, the ETF has shown a relatively stable trend, with its short-term and long-term moving averages indicating a gradual upward trajectory. The current price of 8.04 is slightly above its 20-day simple moving average (SMA) of 8.01, suggesting a potential continuation of the uptrend. The 50-day SMA at 7.82 and 200-day SMA at 7.66 provide further support for this notion, as the price has consistently been trading above these levels. The average true range (ATR) of 0.12, representing 1.52% of the current price, indicates moderate volatility. Given the current technical setup, a potential price target could be the 52-week high of 8.97, with a stop-loss around 7.66 to limit potential losses.

Fundamentally, the ETF has a substantial assets under management (AUM) of 1833.33M EUR, indicating a significant investor base and liquidity. This, combined with the growing importance of the Chinese equity market, positions the ETF for potential long-term growth. As the Chinese economy continues to evolve and expand, the ETF is likely to benefit from the increasing market capitalization of its underlying constituents.

Forecasting the ETFs future performance, we can expect a continued upward trend, driven by the technical indicators and fundamental strengths. Assuming the current trend persists, the ETF may reach the 52-week high of 8.97 in the near term. However, its essential to monitor the ATR and adjust the investment strategy accordingly to manage potential risks. In the long term, the ETFs AUM and the growing Chinese equity market are likely to drive further growth, potentially pushing the price beyond the current 52-week high.

Additional Sources for XCS7 ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

XCS7 ETF Overview

Market Cap in USD 2,160m
Category China Equity
IPO / Inception 2022-04-20

XCS7 ETF Ratings

Growth Rating 24.2
Fundamental -
Dividend Rating 10.0
Rel. Strength -4.09
Analysts -
Fair Price Momentum 7.29 EUR
Fair Price DCF -

XCS7 Dividends

Dividend Yield 12m 2.10%
Yield on Cost 5y 2.41%
Annual Growth 5y -14.81%
Payout Consistency 89.7%
Payout Ratio %

XCS7 Growth Ratios

Growth Correlation 3m 43.5%
Growth Correlation 12m 70.6%
Growth Correlation 5y 11.9%
CAGR 5y 5.39%
CAGR/Max DD 5y 0.15
Sharpe Ratio 12m -0.08
Alpha 12.47
Beta 0.569
Volatility 98.37%
Current Volume 67.8k
Average Volume 20d 5.4k
Stop Loss 7.7 (-3.3%)
What is the price of XCS7 shares?
As of July 09, 2025, the stock is trading at EUR 7.96 with a total of 67,830 shares traded.
Over the past week, the price has changed by +0.82%, over one month by -2.09%, over three months by +10.98% and over the past year by +25.04%.
Is Xtrackers MSCI China 1D a good stock to buy?
Neither. Based on ValueRay´s Analyses, Xtrackers MSCI China 1D is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 24.23 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XCS7 is around 7.29 EUR . This means that XCS7 is currently overvalued and has a potential downside of -8.42%.
Is XCS7 a buy, sell or hold?
Xtrackers MSCI China 1D has no consensus analysts rating.
What are the forecasts for XCS7 share price target?
According to our own proprietary Forecast Model, XCS7 Xtrackers MSCI China 1D will be worth about 8.2 in July 2026. The stock is currently trading at 7.96. This means that the stock has a potential upside of +3.52%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 8.2 3.5%